Close Menu

NEW YORK (GenomeWeb) – DiaSorin and the Tecan Group today announced a collaboration to develop a nucleic acid extraction platform.

Financial and other terms of the deal were not disclosed.

The new platform will leverage Tecan's Fluent Laboratory Automation Solution along with DiaSoriin's Liaison MDX PCR system to provide users a complete sample-to-result system, the firms said, adding the Fluent instrument will be optimized for use with DiaSorin's extraction chemistry and automated PCR technology.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that US states and territories are seeking more funding for the distribution of SARS-CoV-2 vaccines.

The strain now accounts for about 80 percent of cases in Wales and Scotland, and about half of cases in England, the Guardian reports.

A new study suggests that using CRISPR to edit human embryonic DNA can lead to the loss of whole chromosomes, as the Associated Press reports.

In Science this week: ancient dog genomes highlight long ties with humans, genomic analysis of 40,000-year-old early East Asian individual, and more.